Registry of Lung and Chest Cancers Occurring During Pregnancy
Collects information on people with lung or chest cancer who are expecting a child.
Plain-language title generated from the registry record
Registry title: LUCINAE Registry: Thoracic Cancers During Pregnancy
Key facts
- Where
- Baden, Bellinzona, Geneva, and Winterthur, SwitzerlandSee the 4 sites
Where in Switzerland
- Kantonsspital BadenBaden, SwitzerlandTaking people
- Istituto Oncologico della Svizzera Italiana (IOSI)Bellinzona, SwitzerlandTaking people
- Geneva University Hospital (HUG)Geneva, SwitzerlandTaking people
- Kantonsspital WinterthurWinterthur, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Oncology Institute of Southern Switzerland
- Trial code
- NCT07699861
- Record updated
- 21 October 2026
- Original description
The LUCINAE Registry is an international, multicenter observational study collecting data on patients with thoracic cancers (including lung cancer) who are expecting a child. This includes women diagnosed during pregnancy, women who become pregnant during or after cancer, and men receiving cancer treatment at the time their partner conceives.Read full original descriptionShow less
LUCINAE: LUng and Thoracic Cancers In pregNAncy rEgistry
The LUCINAE Registry is an international, multicenter observational study collecting data on patients with thoracic cancers (including lung cancer) who are expecting a child. This includes women diagnosed during pregnancy, women who become pregnant during or after cancer, and men receiving cancer treatment at the time their partner conceives.
Because thoracic cancers during pregnancy are rare, there is limited information to guide clinical decisions. This registry aims to describe patient characteristics, diagnostic approaches, treatments, and maternal and fetal outcomes. Data are collected retrospectively and prospectively from participating centers.
The results of this registry are expected to improve understanding of thoracic cancers in this setting and support the development of future clinical recommendations.
Inclusion: 1. All patients with a diagnosis of thoracic cancer (including lung cancer, mesothelioma, thymic epithelial tumors, neuroendocrine tumors or sarcoma of the thorax and other rare thoracic entities) and pregnancy (positive pregnancy test) including:; Patients receiving a diagnosis of thoracic cancer during pregnancy; Patients who became pregnant while having active thoracic cancer; Patients previously treated for a thoracic cancer and becoming pregnant in the 5 years following end of treatment OR Men with a diagnosis of thoracic cancer (including lung cancer, mesothelioma, thymic epithelial tumors, neuroendocrine tumors or sarcoma of the thorax and other rare thoracic entities), who were undergoing active oncological treatment at the time their partner conceived their child; 2. Available information about pregnancy outcomes; 3. Age ≥ 18 years.
Exclusion: 1. Patient missing data about thoracic cancer stage and diagnosis; 2. For retrospective patients, documented refusal to the use of clinical data for research purposes.